CINCINNATI, June 29 /PRNewswire-FirstCall/ -- Kendle (Nasdaq: KNDL), a leading, global full-service clinical research organization, today announced the appointment of Jarrod Pontius to the position of Chief Legal Officer. In this role, Pontius will provide global leadership for all legal services, corporate governance and general corporate legal matters for Kendle. Pontius will be based in Kendle's global headquarters in Cincinnati and will report to Chairman and Chief Executive Officer, Candace Kendle, PharmD. He will serve on the Company's Executive Committee.
"I am pleased to welcome Jarrod back to Kendle," said Dr. Kendle. "He brings a broad base of legal expertise as well as Kendle experience and we are happy to have a professional of his caliber to lead our global legal team. Jarrod has been instrumental in a number of our recent acquisitions and will be key to the future growth of Kendle."
Pontius brings more than a decade of experience in both the legal and corporate legal environments to Kendle. He has a demonstrated track record of success in the areas of corporate law, mergers and acquisitions, corporate development, public company reporting and securities compliance, corporate financing activities and corporate governance. He rejoins Kendle, from General Cable Corporation, a Fortune 500 publicly traded supplier of wire and cable products, where he had served as Assistant General Counsel since 2007. Previously Pontius was Corporate Counsel and Senior Corporate Counsel from 2002 through 2007 for Kendle. His experience also includes serving as an Associate in the business/corporate department of the Cincinnati law firm Frost Brown Todd LLC.
Pontius is a member of both the Cincinnati and Ohio Bar Associations and the Association of Corporate Counsel and is a graduate of the Cincinnati Academy of Leadership for Lawyers. He received his Juris Doctorate from
Kendle International Inc. (Nasdaq: KNDL) is a leading global clinical research organization providing the full range of early- to late-stage clinical development services for the world's biopharmaceutical industry. Our focus is on innovative solutions that reduce cycle times for our customers and accelerate the delivery of life-enhancing drugs to market for the benefit of patients worldwide. As one of the fastest-growing global providers of Phase I-IV services, we offer experience spanning more than 100 countries, along with industry-leading patient access and retention capabilities and broad therapeutic expertise, to meet our customers' clinical development challenges.
Additional information and investor kits are available upon request from Kendle, 441 Vine Street, Suite 500, Cincinnati, OH 45202 or from the Company's Web site at www.kendle.com.
|SOURCE Kendle International Inc.|
Copyright©2009 PR Newswire.
All rights reserved